Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03487588 · ClinicalTrials.gov registry record · Phase 4
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
A Phase 4 study, sponsored by Aclaris Therapeutics.
- Completed
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT03487588: Completed Phase 4 study, sponsored by Aclaris Therapeutics.
NCT03487588 is a Phase 4 study that has completed, run by Aclaris Therapeutics. The registered enrollment target is 41 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03487588, a Phase 4 study, has completed, sponsored by Aclaris Therapeutics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
Primary Outcome
Subject Satisfaction Questionnaire after treatment with A-101 Topical Solution
Interventions
- DRUG A-101 Topical Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-03-21 |
| Est. Completion | 2018-11-14 |
| Phase | Phase 4 |
What the finished NCT03487588 record still lists
NCT03487588 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which A-101 Topical Solution is the first listed.
NCT03487588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03487588 about?
NCT03487588 is a clinical study titled "An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses". This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
What is the current status of trial NCT03487588?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2018-03-21. Estimated completion is 2018-11-14.
What interventions are being tested in trial NCT03487588?
The interventions under investigation include: A-101 Topical Solution (DRUG).
Who is sponsoring clinical trial NCT03487588?
This trial is sponsored by Aclaris Therapeutics, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03487588's enrollment target sits among peer trials
41 1390th of 2000 higher than 604 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI